Novo Nordisk A/S (NVO)
58.45
-1.19
(-2.00%)
USD |
NYSE |
Jan 14, 13:37
Novo Nordisk Price: 58.45 for Jan. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 215.93 |
| Evaxion AS | 5.08 |
| Regeneron Pharmaceuticals, Inc. | 754.79 |
| Omeros Corp. | 12.87 |
| Viking Therapeutics, Inc. | 34.84 |
Price Related Metrics
| PE Ratio | 17.03 |
| PS Ratio | 5.577 |
| PEG Ratio | 1.504 |
| Price to Book Value | 12.81 |
| Price to Free Cash Flow | 28.16 |
| Earnings Yield | 5.87% |
| Market Cap | 259.72B |
| PEGY Ratio | 1.198 |
| Operating PE Ratio | 13.15 |
| Normalized PE Ratio | 17.03 |